Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
申请人:Turner Sean Colm
公开号:US09266855B2
公开(公告)日:2016-02-23
The present invention relates to novel heterocyclic compounds which are useful for inhibiting glycogen synthase kinase 3 (GSK-3), methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
[EN] HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE LA GLYCOGÈNE SYNTHASE KINASE-3
申请人:ABBOTT GMBH & CO KG
公开号:WO2012041814A1
公开(公告)日:2012-04-05
The present invention relates to novel heterocyclic compounds which are useful for inhibiting glycogen synthase kinase 3 (GSK-3), methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS
申请人:Turner Sean Colm
公开号:US20120077840A1
公开(公告)日:2012-03-29
The present invention relates to novel heterocyclic compounds which are useful for inhibiting glycogen synthase kinase 3 (GSK-3), methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.